Back to Journals » OncoTargets and Therapy » Volume 14

miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]

Authors Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

Received 31 May 2021

Accepted for publication 31 May 2021

Published 3 June 2021 Volume 2021:14 Pages 3597—3598

DOI https://doi.org/10.2147/OTT.S322704

Download Article [PDF] 

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q. Onco Targets Ther. 2018;11:1501—1509.

 

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The journal was notified of alleged image manipulation relating to Figure 3B. Specifically:

The authors were unable to provide a satisfactory explanation for the duplication and the decision was made to retract the paper.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

 

This retraction relates to this paper

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]